Zobrazeno 1 - 10
of 22
pro vyhledávání: '"Lisa Curry"'
Publikováno v:
PLoS ONE, Vol 10, Iss 11, p e0141806 (2015)
Identifying cognitively healthy people at high risk of developing dementia is an ever-increasing focus. These individuals are essential for inclusion in observational studies into the natural history of the prodromal and early disease stages and for
Externí odkaz:
https://doaj.org/article/0bdb80672e5241efbe6b21db3930cb72
Akademický článek
Tento výsledek nelze pro nepřihlášené uživatele zobrazit.
K zobrazení výsledku je třeba se přihlásit.
K zobrazení výsledku je třeba se přihlásit.
Autor:
Parthenia Giannakopoulou, T. Andrews, Geraint Price, D. Perera, Lefkos T. Middleton, Michael T. Ropacki, Bowen Su, Nzeera Ketter, Heather Ward, Lisa Curry, Josip Car, H. M. Arrighi, Catherine Robb, Chinedu T. Udeh-Momoh, Darina Bassil, H. R. Brashear, Gerald Novak, Martin Cohn, Robert Perneczky
Publikováno v:
The journal of prevention of Alzheimer's disease 6(4), 256-266 (2019). doi:10.14283/JPAD.2019.31
Background: The CHARIOT PRO Main study is a prospective, non-interventional study evaluating cognitive trajectories in participants at the preclinical stage of Alzheimer’s disease (AD) classified by risk levels for developing mild cognitive impairm
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::c825f42e577116d7cdf5f8b151134483
Autor:
Sabina Sieri, Paolo Vineis, Meghan Kapur, Robert Luben, Federico C. F. Calboli, Carol Brayne, Bahram V. Foroutanpay, Valentina Gallo, Haining Zhu, Giovanna Masala, Diana Gavrila, Carles Gaig, Druckerei Stückle, Manja Kloss, Oriol Grau-Rivera, Alberto Bergareche, Jesper Petersson, Su Jin Choi, Albert Lladó, Xia Wu, Xiaotong Wen, Daniel Lindqvist, Roger A. Barker, Birgit Teucher, Larraitz Arriola, Youzhi Lai, Silvia Ramat, Salvatore Panico, Ellen Gelpi, Oskar Hansson, José Luis Molinuevo, Meinie Seelen, Lefkos T. Middleton, Raquel Sánchez-Valle, Verena Katzke, Sabata Martino, Ilaria Bicchi, Isidro Ferrer, Ming Li, Dimitar Ourdev, Antonia Thricopolou, Tso-Pang Yao, Maria Elena Erro, Yumei Zhang, Angelo L. Vescovi, Lisa Curry, Bas Bueno-de-Mesquita, Lianna Ishihara, Andreas Kyrozis, Satyabrata Kar, Hak-June Kim, Li Yao, Roel Vermeulen, Rudolf Kaaks, Claudio Ruffmann, Elio Riboli, Satz Mengensatzproduktion, Amalia Mattiello, Albert Saiz, Lars Forsgren, Song-Yi Park, Nicola Vanacore, Yoshiharu Kawaguchi, Carlotta Sacerdote, Carlos Nos, Francesc Graus, Carla Emiliani, Joo-Yong Lee, Yanlin Wang
Publikováno v:
Neurodegenerative Diseases. 15:I-IV
Publikováno v:
Alzheimer's & Dementia. 13
Autor:
Lisa Curry
Publikováno v:
The Innes Review. 59:49-76
The following compilation of letters date from between 1845 and 1854; they form part of a larger collection of papers relating to Christina Gordon and her descendants, which are currently in the author's possession.1 The bulk of the letters included
Autor:
Lisa Curry, Michael J. Detke, Janet B. W. Williams, Earl L. Giller, Kenneth A. Kobak, David S. Reasner
Publikováno v:
Journal of clinical psychopharmacology. 35(6)
Lack of standardization across sites and raters, poor interrater reliability, and possible scoring bias affecting the primary outcome measure contribute to a high failure rate in anxiety trials. Remote centralized raters who are blinded to protocol i
One-year safety and efficacy study of arformoterol tartrate in patients with moderate to severe COPD
Autor:
Donald A. Mahler, Alistair Wheeler, James F. Donohue, Robert Tosiello, Donald P. Tashkin, Barry J. Make, Matthew C. Miles, Lisa Curry, Nicola A. Hanania
Publikováno v:
Chest
BACKGROUND: Arformoterol tartrate (arformoterol, 15 μg bid) is a nebulized long-acting β 2 -agonist approved for maintenance treatment of COPD. METHODS: This was a multicenter, double-blind, randomized, placebo-controlled study. Patients (aged ≥
Autor:
Mair, Lisa Curry
Publikováno v:
Mother Earth News. Jun/Jul2006, Issue 216, p104-107. 4p.
Autor:
Karen Ritchie, Lisa Curry, Sonia Marquardt, Danielle Wilson, Cerian Avent, Craig W. Ritchie, Sarah Gregory, Lauren Pae
Publikováno v:
International psychogeriatrics. 25(6)
Background: Connecting willing patients with dementia to suitable clinical research studies has been historically challenging. The United Kingdom Dementia and Neurodegenerative Research Network (DeNDRoN) was established to link patients into high-qua